Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2020 | 04-2020 | 01-2020 | 10-2019 | 07-2019 | |
| Operating Expenses | 838 | 506 | 1,428 | 1,168 | 1,171 |
| Operating Income | -838 | -506 | -1,428 | -1,168 | -1,171 |
| Interest Expense | 21 | 4 | 3 | 2 | 3 |
| Other Income | 19 | 0 | 0 | -75 | 15 |
| Pre-tax Income | -840 | -509 | -1,431 | -1,244 | -1,160 |
| Net Income Continuous | -840 | -509 | -1,431 | -1,244 | -1,170 |
| Net Income | $-840 | $-509 | $-1,431 | $-1,244 | $-1,170 |
| EPS Basic Total Ops | 548.87 | -0.84 | -2.00 | -551.67 | 0.22 |
| EPS Basic Continuous Ops | 549.78 | -0.71 | -1.98 | -552.73 | -1.80 |
| EPS Diluted Total Ops | 548.87 | -0.84 | -2.00 | -551.67 | 0.22 |
| EPS Diluted Continuous Ops | 549.78 | -0.71 | -1.98 | -552.73 | -1.80 |
| EBITDA(a) | $-833 | $-503 | $-1,424 | $-1,164 | $-1,168 |